Patent · US Active

Synthetic vaccines against Streptococcus pneumoniae type 1

US10328141B2 · kind B2 · utility

3Cited by

0References

7Claims

0Family size

Assignee

Max-Planck-Gesellschaft zur Föderung der Wissenschaften e.V. · US

Inventors

Peter H. Seeberger · Potsdam, DE
Claney Lebev Pereira · Berlin, DE
Chakkumkal Anish · The Hague, NL
Benjamin Schumann · Berlin, DE

Key dates

Filing date	Jul 7, 2014
Grant date	Jun 25, 2019
Priority date	—
Expiry date	Dec 18, 2034

Classification

Technology area (CPC G)Physics
CPC primaryG01N2469/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the total synthesis of saccharide structures contained in the capsular polysaccharide of Streptococcus pneumoniae type 1, to glycoconjugates containing said saccharide structures obtained by total synthesis and to use of such glycoconjugates and pharmaceutical compositions thereof in the immunization against diseases associated with bacteria containing said saccharide structures in their capsular polysaccharide, and more specifically associated with Streptococcus pneumoniae.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.